JACC-Heart Failure is a premier journal in the field of cardiology, published by Elsevier Science Ltd, that has rapidly established itself as a vital resource for researchers and practitioners focused on heart failure and cardiovascular health. With an impressive impact factor and ranking in the Q1 category for Cardiology and Cardiovascular Medicine, this journal is recognized for its high-quality peer-reviewed articles that contribute significantly to advancements in clinical practice and scientific understanding of heart failure. As of 2023, the journal ranks #10 out of 387 in its field, positioning it in the 97th percentile of Scopus rankings, which highlights its influential role in disseminating cutting-edge research. Although the journal does not operate under an open-access model, it maintains a rigorous review process, ensuring the publication of articles that are both innovative and clinically relevant. Targeting an audience of dedicated researchers, healthcare professionals, and students, JACC-Heart Failure serves as an essential platform for exploring the complexities of heart failure treatments, management strategies, and future directions in cardiology.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, the esteemed publication of Elsevier Science Inc, stands as a premier platform for advancing knowledge in the field of cardiology and cardiovascular medicine. With an impressive impact factor reflecting its prominence—ranked Q1 in its category for 2023 and occupying the 4th position out of 387 in the Scopus listings, firmly placing it in the 99th percentile—this journal is essential for researchers, clinicians, and students alike. Since its inception in 1983, it has continuously provided a vital space for high-quality research and innovative clinical practices, driving forward our understanding of cardiovascular health. While access options are not open, the value of the cutting-edge articles published here cannot be overstated, as they foster collaboration and inform better patient care across the globe. As part of its ongoing commitment to excellence, the journal solicits submissions of original research, reviews, and clinical studies that contribute meaningfully to the field and engage its diverse readership.

Welcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.

TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.

Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.

Cardiac Failure Review, published by Radcliffe Cardiology, is a leading open-access journal dedicated to advancing the understanding and management of cardiac failure. With an ISSN of 2057-7540 and an E-ISSN of 2057-7559, this journal has gained significant recognition in the field, achieving a Q1 ranking in Cardiology and Cardiovascular Medicine as of 2023. Its impressive positioning at rank #97 out of 387 in Scopus further highlights its impact, placing it within the top 25th percentile of its category. Since transitioning to open access in 2019, Cardiac Failure Review has become increasingly accessible, ensuring that critical research findings are available to a global audience. The journal's focus spans innovative treatments, emerging technologies, and comprehensive reviews, effectively meeting the needs of researchers, clinicians, and students alike. With a commitment to excellence in cardiovascular medicine, Cardiac Failure Review plays a vital role in disseminating knowledge and fostering discussions that drive the field forward.

HEART FAILURE REVIEWS is a premier academic journal published by Springer, dedicated to the dynamic field of cardiology and cardiovascular medicine. With an impressive Q1 ranking in 2023, the journal stands as a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments in heart failure management and research. Covering a broad spectrum of topics, including innovative therapies, epidemiology, and pathophysiology of heart failure, it fosters an environment for interdisciplinary collaboration. The journal is indexed with an ISSN of 1382-4147 and an E-ISSN of 1573-7322, ensuring widespread dissemination of knowledge. Although it does not currently offer open access options, its rigorous peer-review process guarantees high-quality content that contributes significantly to the scientific community. Established in 1996 and running through 2024, HEART FAILURE REVIEWS continues to be a leading platform for advancing understanding and treatment of heart conditions, making it an indispensable resource for all stakeholders in cardiac health.

IJC Heart & Vasculature is a premier open-access journal published by Elsevier Ireland Ltd, dedicated to advancing research in the fields of cardiology and cardiovascular medicine. Since its inception in 2013, this journal has established itself as a valuable resource for clinicians, researchers, and students keen on exploring the latest developments in heart and vascular health. With an impressive impact factor and ranked within Q2 in its category (2023), IJC Heart & Vasculature has achieved a significant Scopus rank of #125 out of 387, placing it in the 67th percentile of cardiology journals. The journal not only emphasizes high-quality research but also promotes innovative studies that can shape clinical practices and improve patient outcomes. Researchers and professionals can access a plethora of peer-reviewed articles, original research, and comprehensive reviews that unravel the complexities of cardiovascular science. With a commitment to fostering open and impactful dialogue in the field, IJC Heart & Vasculature is poised to be an essential platform for knowledge exchange in the evolving landscape of cardiovascular research.

The European Journal of Heart Failure, published by Wiley, is a premier international journal dedicated to advancing the field of cardiology, specifically focusing on heart failure research and clinical practices. With an impressive impact factor and ranked in the top 1% of journals in Cardiology and Cardiovascular Medicine according to Scopus rankings (Rank #7/387, Percentile 98th), this journal serves as a vital resource for researchers, clinicians, and students alike. Spanning from 1999 to 2024, the journal has established itself as a cornerstone for innovative research, comprehensive reviews, and clinical insights, fostering a deeper understanding of heart failure mechanisms, management, and treatment strategies. Although not an open-access journal, the European Journal of Heart Failure remains committed to disseminating high-quality, peer-reviewed content that contributes significantly to the global cardiovascular community. Located in the United States at 111 River St, Hoboken, NJ 07030-5774, it continues to play an essential role in shaping the future of heart failure management.